Mylan Laboratories Limited Heparin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Heparin Export Records India — #5 Exporter, 66 Shipments, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Heparin

India Pharmaceutical Trade Intelligence

$352.8M391 Suppliers137 CountriesHS 30049099

ExportsIndia → UNITED STATES42.1%India → SAUDI ARABIA12.3%

ImportsCHINA → India$508.4B BELGIUM → India$2.8B

#1 Supplier: GLAND PHARMA #1 Buyer: FRESENIUS KABI

Mylan Laboratories Limited — Heparin Exporter #5 | $3.3M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Heparin Exporter Profile

Indian Pharmaceutical Exporter · #5 for Heparin · $3.3M export value · DGFT Verified

Mylan Laboratories Limited is the #5 Indian exporter of Heparin with $3.3M in export value and 66 verified shipments. Mylan Laboratories Limited holds a 1.4% market share in Heparin exports across 1 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Heparin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Heparin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Heparin?

Country	Value	Shipments	Share
UNITED STATES	$51.9M	1,037	47.6%
SAUDI ARABIA	$11.7M	233	10.7%
PHILIPPINES	$10.3M	206	9.5%
THAILAND	$5.9M	118

Who Are the Top Buyers of Heparin from India?

Buyer	Country	Value	Orders
FRESENIUS KABI USA, LLC	UNITED STATES	$19.4M	387
EVERSANA	UNITED STATES	$13.4M	268
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$11.2M	223
FRESENIUS KABI USA LLC	UNITED STATES	$3.5M	69
MYLAN INSTITUTIONAL INC 2898	UNITED STATES	$2.9M	57
EVERSANA EVERSANA	UNITED STATES	$2.2M	44
E U PHARMACEUTICALS CO.,LTD	THAILAND	$1.4M	28
NUEVOS ETICOS NEOETHICALS, S.A.	GUATEMALA	$1.1M	22
HOSPIRA INC	UNITED STATES	$950.0K	19
XXSPIXX INX	UNITED STATES	$600.0K	12

India's Heparin is purchased by 854 buyers worldwide. The top buyer is FRESENIUS KABI USA, LLC (UNITED STATES), followed by EVERSANA and BOSTON ONCOLOGY ARABIA.

How Does Mylan Laboratories Limited Compare to Nearest Heparin Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	CAPLIN POINT LABORATORIES LIMITED	$3.7M	74	4	$50.0K
7	TROIKAA PHARMACEUTICALS LIMITED	$3.6M	72	8	$50.0K
5	MYLAN LABORATORIES LIMITED ★	$3.3M	66	1	$50.0K
14	SCOTT EDIL PHARMACIA LIMITED	$1.7M	53	10	$32.8K
4	PFIZER HEALTHCARE INDIA PRIVATE LIMITED	$1.6M	31	1	$50.0K

Mylan Laboratories Limited ranks #5 among 391 Indian Heparin exporters. Average shipment value of $50.0K compared to the market average of $288.0K. The closest competitors by value are CAPLIN POINT LABORATORIES LIMITED and TROIKAA PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Heparin Exports?

Port	Shipments	% Share
HYDERABAD ICD	669	14.6%
SAHAR AIR CARGO ACC (INBOM4)	507	11.1%
HYDERABAD ICD (INSNF6)	486	10.6%
SAHAR AIR	441	9.6%
DELHI AIR CARGO ACC (INDEL4)	221	4.8%
NHAVA SHEVA SEA (INNSA1)	213	4.6%
Bombay Air	156	3.4%
HYDERABAD AIR	153	3.3%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Heparin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 137+ countries, 854+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Heparin

Heparin

Mylan Laboratories Limited — Heparin Exporter Profile

Mylan Laboratories Limited — Heparin Export Profile: Buyers & Destinations

Where Does India Export Heparin?

Who Are the Top Buyers of Heparin from India?

What Is India's Total Heparin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Heparin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Heparin Exporters?

Regulatory Requirements: Exporting Heparin to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Heparin Exporters?

Which Indian Ports Ship Heparin Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Heparin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Heparin Export Data from Mylan Laboratories Limited

Heparin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source